Adiponectin, driver or passenger on the road to insulin sensitivity?

[1]  P. Scherer,et al.  Adipocytes: impact on tumor growth and potential sites for therapeutic intervention. , 2013, Pharmacology & therapeutics.

[2]  J. Kizer.  A Tangled Threesome: Adiponectin, Insulin Sensitivity, and Adiposity , 2013, Diabetes.

[3]  T. Kadowaki,et al.  Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. , 2013, Cell metabolism.

[4]  P. Scherer,et al.  Adiponectin promotes functional recovery after podocyte ablation. , 2013, Journal of the American Society of Nephrology : JASN.

[5]  E. Ingelsson,et al.  Abstract 11824: Evidence of a Causal Relationship between Adiponectin Levels and Insulin Sensitivity: A Mendelian Randomization Study , 2012 .

[6]  H. Parkington,et al.  Adiponectin increases insulin content and cell proliferation in MIN6 cells via PPARγ‐dependent and PPARγ‐independent mechanisms , 2012, Diabetes, obesity & metabolism.

[7]  S. Hunt,et al.  Adipocyte iron regulates adiponectin and insulin sensitivity. , 2012, The Journal of clinical investigation.

[8]  Y. Deshaies,et al.  Lack of “immunological fitness” during fasting in metabolically challenged animals[S] , 2012, Journal of Lipid Research.

[9]  P. Scherer,et al.  Adiponectin: mechanistic insights and clinical implications , 2012, Diabetologia.

[10]  S. Summers,et al.  A ceramide-centric view of insulin resistance. , 2012, Cell metabolism.

[11]  C. Mantzoros,et al.  The role of adiponectin in cancer: a review of current evidence. , 2012, Endocrine reviews.

[12]  J. Després,et al.  Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study). , 2011, The American journal of cardiology.

[13]  K. Dellsperger,et al.  Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice. , 2011, American journal of physiology. Heart and circulatory physiology.

[14]  A. Khera,et al.  Adipose tissue mass and location affect circulating adiponectin levels , 2011, Diabetologia.

[15]  Y. Liu,et al.  Adiponectin Action: A Combination of Endocrine and Autocrine/Paracrine Effects , 2011, Front. Endocrin..

[16]  A. Xu,et al.  Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice. , 2011, Cell metabolism.

[17]  Mi-Hye Lee,et al.  Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo. , 2011, American journal of physiology. Endocrinology and metabolism.

[18]  P. Scherer,et al.  Adipose tissue remodeling and obesity. , 2011, The Journal of clinical investigation.

[19]  K. Kaestner,et al.  Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. , 2011, The Journal of clinical investigation.

[20]  C. Ayers,et al.  Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution , 2011, Diabetes & vascular disease research.

[21]  S. Furth,et al.  Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease , 2011, Pediatric Nephrology.

[22]  S. Akira,et al.  Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. , 2011, Cell metabolism.

[23]  C. Zoccali,et al.  Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers? , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[24]  M. Birnbaum,et al.  Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.

[25]  F. Liu,et al.  APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway. , 2011, American journal of physiology. Endocrinology and metabolism.

[26]  P. Ruiz-Lozano,et al.  T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.

[27]  T. Funahashi,et al.  Local induction of adiponectin reduces lipopolysaccharide-triggered skeletal muscle damage. , 2010, Endocrinology.

[28]  M. Fasshauer,et al.  Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.

[29]  Aamir Suhail,et al.  Adiponectin-induced ERK and Akt Phosphorylation Protects against Pancreatic Beta Cell Apoptosis and Increases Insulin Gene Expression and Secretion* , 2010, The Journal of Biological Chemistry.

[30]  Bradley H. Crotty,et al.  B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case–control study in Greece , 2010, Cancer Causes & Control.

[31]  H. Randeva,et al.  Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin , 2010, Peptides.

[32]  Y. Hayashi,et al.  Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1 , 2010, Nature.

[33]  P. Scherer,et al.  Enhanced metabolic flexibility associated with elevated adiponectin levels. , 2010, The American journal of pathology.

[34]  Yajing Wang,et al.  Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. , 2010, American journal of physiology. Endocrinology and metabolism.

[35]  C. Vrints,et al.  Functional Adiponectin Resistance at the Level of the Skeletal Muscle in Mild to Moderate Chronic Heart Failure , 2010, Circulation. Heart failure.

[36]  T. Leff,et al.  Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. , 2010, American journal of physiology. Endocrinology and metabolism.

[37]  K. Walsh,et al.  Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype* , 2009, The Journal of Biological Chemistry.

[38]  C. Mantzoros,et al.  Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  N. Stanietsky,et al.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity , 2009, Proceedings of the National Academy of Sciences.

[40]  M. Hamilton,et al.  Systemic Fate of the Adipocyte-Derived Factor Adiponectin , 2009, Diabetes.

[41]  K. Sharma.  The link between obesity and albuminuria: adiponectin and podocyte dysfunction. , 2009, Kidney international.

[42]  Y. Liu,et al.  Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment. , 2009, American journal of physiology. Endocrinology and metabolism.

[43]  J. Pollard,et al.  Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo , 2009, Clinical Cancer Research.

[44]  Dorothy D. Sears,et al.  FOXO1 Transrepresses Peroxisome Proliferator-activated Receptor γ Transactivation, Coordinating an Insulin-induced Feed-forward Response in Adipocytes* , 2009, Journal of Biological Chemistry.

[45]  S. Kihara,et al.  Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism , 2009, Molecular and Cellular Biology.

[46]  N. Bardeesy,et al.  Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. , 2009, Biochemical and biophysical research communications.

[47]  Tsonwin Hai,et al.  Adipocyte CREB promotes insulin resistance in obesity. , 2009, Cell metabolism.

[48]  Meilian Liu,et al.  Transcriptional and post-translational regulation of adiponectin. , 2009, The Biochemical journal.

[49]  C. Mantzoros,et al.  Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study , 2009, Cancer Causes & Control.

[50]  Feng Liu,et al.  A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization , 2008, Proceedings of the National Academy of Sciences.

[51]  P. Scherer,et al.  DsbA-L is a versatile player in adiponectin secretion , 2008, Proceedings of the National Academy of Sciences.

[52]  T. Kadowaki,et al.  5‐Hydroxytryptamine 2A receptor signaling cascade modulates adiponectin and plasminogen activator inhibitor 1 expression in adipose tissue , 2008, FEBS letters.

[53]  H. Parving,et al.  Elevated levels of high-molecular-weight adiponectin in type 1 diabetes. , 2008, The Journal of clinical endocrinology and metabolism.

[54]  Y. Liu,et al.  Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function. , 2008, American journal of physiology. Cell physiology.

[55]  P. Scherer,et al.  Plasma adiponectin complexes have distinct biochemical characteristics. , 2008, Endocrinology.

[56]  S. Summers,et al.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. , 2008, Endocrine reviews.

[57]  大塚 文之.  Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease , 2008 .

[58]  H. Yoshiji,et al.  Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats. , 2007, International journal of molecular medicine.

[59]  J. McNeill,et al.  Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats. , 2007, Metabolism: clinical and experimental.

[60]  J. Hokanson,et al.  Determinants of serum adiponectin in persons with and without type 1 diabetes. , 2007, American journal of epidemiology.

[61]  G. Shulman,et al.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.

[62]  Qinglin Yang,et al.  Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. , 2007, Journal of molecular and cellular cardiology.

[63]  D. Dunger,et al.  Paradoxical Elevation of High–Molecular Weight Adiponectin in Acquired Extreme Insulin Resistance Due to Insulin Receptor Antibodies , 2007, Diabetes.

[64]  B. Goldstein,et al.  Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. , 2007, The Journal of clinical investigation.

[65]  C. Mantzoros,et al.  Low adiponectin levels are associated with renal cell carcinoma: A case‐control study , 2007, International journal of cancer.

[66]  P. Scherer,et al.  Secretion of the Adipocyte-Specific Secretory Protein Adiponectin Critically Depends on Thiol-Mediated Protein Retention , 2007, Molecular and Cellular Biology.

[67]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[68]  M. Bohlooly-y,et al.  Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism , 2007, Diabetes.

[69]  S. Kash,et al.  Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. , 2007, Endocrinology.

[70]  K. Kos,et al.  Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum , 2007, Diabetologia.

[71]  J. Shao,et al.  SIRT1 Regulates Adiponectin Gene Expression through Foxo1-C/Enhancer-binding Protein α Transcriptional Complex* , 2006, Journal of Biological Chemistry.

[72]  Vineet Chopra,et al.  Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. , 2006, European heart journal.

[73]  M. J. Yoon,et al.  Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator–Activated Receptor α , 2006, Diabetes.

[74]  J. Danesh,et al.  Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis , 2006, Circulation.

[75]  S. Brichard,et al.  Induction of adiponectin in skeletal muscle of type 2 diabetic mice: in vivo and in vitro studies , 2006, Diabetologia.

[76]  D. Boyle,et al.  Intracellular Trafficking and Secretion of Adiponectin Is Dependent on GGA-coated Vesicles* , 2006, Journal of Biological Chemistry.

[77]  N. Ruderman,et al.  Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists* , 2006, Journal of Biological Chemistry.

[78]  C. Mantzoros,et al.  Adiponectin in relation to childhood myeloblastic leukaemia , 2006, British Journal of Cancer.

[79]  W. Willett,et al.  Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. , 2005, Journal of the National Cancer Institute.

[80]  R. Piñeiro,et al.  Adiponectin is synthesized and secreted by human and murine cardiomyocytes , 2005, FEBS letters.

[81]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[82]  L. Campbell,et al.  The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. , 2005, European journal of endocrinology.

[83]  H. Brenner,et al.  Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. , 2005, European heart journal.

[84]  Remi Rabasa-Lhoret,et al.  The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.

[85]  J. Eckel,et al.  Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. , 2005, Diabetes.

[86]  W. Garvey,et al.  Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400373-JLR200 , 2005, Journal of Lipid Research.

[87]  B. Howard,et al.  Adiponectin and coronary heart disease: the Strong Heart Study. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[88]  E. Rimm,et al.  Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.

[89]  S. Brichard,et al.  Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. , 2004, Endocrinology.

[90]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[91]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[92]  C. Mantzoros,et al.  Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.

[93]  P. Arner,et al.  Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. , 2004, The Journal of clinical endocrinology and metabolism.

[94]  D. Eizirik,et al.  Expression of adiponectin receptors in pancreatic beta cells. , 2003, Biochemical and biophysical research communications.

[95]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[96]  S. Kihara,et al.  Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. , 2003, Kidney international. Supplement.

[97]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[98]  C. Mantzoros,et al.  Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. , 2003, The Journal of clinical endocrinology and metabolism.

[99]  P. Froguel,et al.  Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis* , 2003, The Journal of Biological Chemistry.

[100]  H. Lodish,et al.  Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[101]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[102]  P. Saha,et al.  Increased β-Oxidation but No Insulin Resistance or Glucose Intolerance in Mice Lacking Adiponectin* , 2002, The Journal of Biological Chemistry.

[103]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[104]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[105]  P. Scherer,et al.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.

[106]  L. Rossetti,et al.  Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. , 2001, The Journal of clinical investigation.

[107]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[108]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[109]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[110]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[111]  Philipp E. Scherer,et al.  The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor , 1998, Current Biology.

[112]  Y. Nakano,et al.  Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.

[113]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[114]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[115]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[116]  H. Lodish.  Molecular Cell Biology , 1986 .

[117]  Arthur P. Grollman,et al.  Pharmacology and Therapeutics , 1963 .